Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Respirology
    February 2024
  1. JENKINS CR, Bardin P
    The long and winding road-Where to now for asthma?
    Respirology. 2024 Feb 29. doi: 10.1111/resp.14690.
    >> Share

  2. ROTHE T, Ubags N, von Garnier C
    What makes asthma characterized by airway eosinophilia become severe?
    Respirology. 2024 Feb 25. doi: 10.1111/resp.14685.
    >> Share

  3. LE SOUEF PN
    Asthma in children-What's in the future.
    Respirology. 2024 Feb 21. doi: 10.1111/resp.14670.
    >> Share

  4. MCDONALD CF
    Letter from Australia.
    Respirology. 2024;29:187-188.
    >> Share

    January 2024
  5. WENG CM, Wu WC, Lee MJ, Chen MC, et al
    Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma.
    Respirology. 2024 Jan 31. doi: 10.1111/resp.14663.
    >> Share

  6. MCDONALD VM, Holland AE
    Treatable traits models of care.
    Respirology. 2024;29:24-35.
    >> Share

  7. LAVERCOMBE M
    Recommendations from The Medical Education Editor.
    Respirology. 2024;29:5-7.
    >> Share

  8. NEFFEN HE, Maillo M
    Letter from Argentina.
    Respirology. 2024;29:82-83.
    >> Share

  9. SENARATNA CV, Lowe A, Walters EH, Abramson MJ, et al
    Associations of early life and childhood risk factors with obstructive sleep apnoea in middle-age.
    Respirology. 2024;29:63-70.
    >> Share

    December 2023
  10. JENKINS CR
    Mild asthma: Conundrums, complexities and the need to customize care.
    Respirology. 2023 Dec 25. doi: 10.1111/resp.14646.
    >> Share

  11. THOMAS M, Beasley R
    The treatable traits approach to adults with obstructive airways disease in primary and secondary care.
    Respirology. 2023;28:1101-1116.
    >> Share

  12. GRAY DM
    In case you missed it.
    Respirology. 2023;28:1171-1172.
    >> Share

    November 2023
  13. HATCH M, Lilburn P, Scott C, Ing A, et al
    Safety and efficacy of bronchial thermoplasty in Australia 5 years post-procedure.
    Respirology. 2023;28:1053-1059.
    >> Share

    September 2023
  14. MCDONALD VM, Archbold G, Beyene T, Brew BK, et al
    Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement.
    Respirology. 2023 Sep 15. doi: 10.1111/resp.14593.
    >> Share

  15. YASARATNE D, Idrose NS, Dharmage SC
    Asthma in developing countries in the Asia-Pacific Region (APR).
    Respirology. 2023 Sep 13. doi: 10.1111/resp.14590.
    >> Share

  16. BAN AY, Ng BH, Nik Abeed NN
    Letter from Malaysia.
    Respirology. 2023;28:890-891.
    >> Share

    August 2023
  17. LANGTON D, Politis J, Collyer T, Khung SW, et al
    Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics.
    Respirology. 2023 Aug 28. doi: 10.1111/resp.14578.
    >> Share

  18. KO FWS
    Can we predict asthma exacerbations?
    Respirology. 2023 Aug 23. doi: 10.1111/resp.14583.
    >> Share

  19. HARVEY ES, Peters MJ
    Asthma registries: Tedious paperwork or a versatile tool for the generation of knowledge-Insights from the Australasian Severe Asthma Registry (ASAR).
    Respirology. 2023 Aug 23. doi: 10.1111/resp.14585.
    >> Share

  20. REYNOLDS PN, Ansari S, Hernandez-Sebastian R, Boonsawat W, et al
    Towards regional progress: APSR 2022 Big Five Lung Diseases Workshop.
    Respirology. 2023;28:807-816.
    >> Share

    July 2023
  21. GIBSON PG, McDonald VM, Thomas D
    Treatable traits, combination inhaler therapy and the future of asthma management.
    Respirology. 2023 Jul 30. doi: 10.1111/resp.14556.
    >> Share

  22. KO FWS, Salvi S
    Minimize systemic oral corticosteroids use and reduce harm for patients with asthma.
    Respirology. 2023 Jul 4. doi: 10.1111/resp.14551.
    >> Share

  23. MALHOTRA A, Razak A
    Risk of childhood asthma in those born small.
    Respirology. 2023 Jul 1. doi: 10.1111/resp.14546.
    >> Share

    June 2023
  24. KIM HS, Lee SW, Kim JT, Kim JH, et al
    Fetal growth rather than prematurity determines lung function in children with asthma.
    Respirology. 2023 Jun 12. doi: 10.1111/resp.14528.
    >> Share

  25. DHAR R, Rhee CK, Perng DW, Fukunaga K, et al
    The burden of systemic corticosteroid use in asthma management in Asia.
    Respirology. 2023 Jun 10. doi: 10.1111/resp.14533.
    >> Share

    May 2023
  26. SHAH PA, Brightling C
    Biologics for severe asthma-Which, when and why?
    Respirology. 2023 May 24. doi: 10.1111/resp.14520.
    >> Share

  27. HANCOX RJ, Bardin PG
    Asthma research priorities: Listening to everybody.
    Respirology. 2023 May 22. doi: 10.1111/resp.14522.
    >> Share

  28. BRUSSELLE G, Riemann S, Maes T
    Mepolizumab attenuates ILC2s proliferation and activity in adults with severe eosinophilic asthma.
    Respirology. 2023 May 10. doi: 10.1111/resp.14517.
    >> Share

  29. BLOOM CI
    Covid-19 pandemic and asthma: What did we learn?
    Respirology. 2023 May 8. doi: 10.1111/resp.14515.
    >> Share

  30. CHI-LEUNG D
    The big 5 respiratory diseases give insight into respiratory health and beyond.
    Respirology. 2023;28:496-497.
    >> Share

  31. CLEMM HSH
    Letter from Norway.
    Respirology. 2023;28:500-501.
    >> Share

  32. FLYNN C, Brightling C
    Is FeNOtyping in COPD the path to precision medicine?
    Respirology. 2023;28:421-422.
    >> Share

  33. FINLAY P, Smith E
    Bronchial provocation testing: Should we look beyond FEV(1) ?
    Respirology. 2023;28:419-420.
    >> Share

  34. PARKER J, Tzeng A, Wayne S, Haynes JM, et al
    Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing.
    Respirology. 2023;28:437-444.
    >> Share

    April 2023
  35. MALIK B, Bartlett NW, Upham JW, Nichol KS, et al
    Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics.
    Respirology. 2023 Apr 28. doi: 10.1111/resp.14506.
    >> Share

  36. KOH J, Phyland D, Ruane L, Avram A, et al
    Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction.
    Respirology. 2023;28:406-408.
    >> Share

    March 2023
  37. VU HD, Shafuddin E, Willis J, Pallin M, et al
    Monoclonal antibody therapy in cystic fibrosis and asthma.
    Respirology. 2023 Mar 28. doi: 10.1111/resp.14498.
    >> Share

  38. MAJELLANO EC, Bell RL, Flynn AW, Mckenzie A, et al
    Identifying the asthma research priorities of people with asthma, their carers and other stakeholders.
    Respirology. 2023 Mar 15. doi: 10.1111/resp.14492.
    >> Share

  39. AL-SHAIKHLY T, Murphy RC, Lai Y, Frevert CW, et al
    Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma.
    Respirology. 2023 Mar 13. doi: 10.1111/resp.14491.
    >> Share

  40. DONOVAN GM, Wang KCW, Elliot JG, James AL, et al
    Quantifying airway remodelling for research or clinical purposes: How should we normalize for airway size?
    Respirology. 2023;28:223-225.
    >> Share

  41. COATES AL
    How does one get around many of the confounding factors influencing the response to methacholine?
    Respirology. 2023;28:204-205.
    >> Share

  42. HENRY C, Boucher M, Boulay ME, Cote A, et al
    The cumulative effect of methacholine on large and small airways when deep inspirations are avoided.
    Respirology. 2023;28:226-235.
    >> Share

    February 2023
  43. ADRISH M, Hanania NA
    Asthma and cardiovascular disease: A bidirectional association?
    Respirology. 2023 Feb 7. doi: 10.1111/resp.14468.
    >> Share

    January 2023
  44. KO FWS
    Severe asthma, more than that?
    Respirology. 2023 Jan 17. doi: 10.1111/resp.14453.
    >> Share

  45. YU S, Lee SC, Hong JH, Han CH, et al
    Cardiovascular and cerebrovascular mortality in patients with preceding asthma exacerbation.
    Respirology. 2023 Jan 3. doi: 10.1111/resp.14444.
    >> Share

  46. HANCOX RJ, Chang CL
    The ill winds of COVID-19: How the pandemic improved respiratory health for some.
    Respirology. 2023;28:13-14.
    >> Share

  47. KO FWS, Lau LHS, Ng SS, Yip TCF, et al
    Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates.
    Respirology. 2023;28:47-55.
    >> Share

    November 2022
  48. GIBSON PG
    Adding some NOVELTY to treatable traits.
    Respirology. 2022;27:912-913.
    >> Share

  49. AGUSTI A, Rapsomaniki E, Beasley R, Hughes R, et al
    Treatable traits in the NOVELTY study.
    Respirology. 2022;27:929-940.
    >> Share

    October 2022
  50. FOONG RE, Franklin P, Sanna F, Hall GL, et al
    Longitudinal effects of prenatal exposure to plastic-derived chemicals and their metabolites on asthma and lung function from childhood into adulthood.
    Respirology. 2022 Oct 2. doi: 10.1111/resp.14386.
    >> Share

    September 2022
  51. PRICE D, Uthaman T
    What have we learnt from real-life research in asthma and COPD? Standards and novel designs for the future.
    Respirology. 2022 Sep 29. doi: 10.1111/resp.14381.
    >> Share

  52. ADRISH M, Hanania NA
    Choosing and switching biological agents in severe asthma.
    Respirology. 2022 Sep 26. doi: 10.1111/resp.14377.
    >> Share

  53. PASSOS NF, Freitas PD, Carvalho-Pinto RM, Cukier A, et al
    Increased physical activity reduces sleep disturbances in asthma: A randomized controlled trial.
    Respirology. 2022 Sep 6. doi: 10.1111/resp.14359.
    >> Share

  54. HASHMI MD, Khan A, Shafiq M
    Bronchial thermoplasty: State of the art.
    Respirology. 2022;27:720-729.
    >> Share

    August 2022
  55. NEDER JA, O'Donnell DE
    The severe asthma-obesity conundrum: Consequences for exertional dyspnoea and exercise tolerance in men and women.
    Respirology. 2022 Aug 17. doi: 10.1111/resp.14346.
    >> Share

  56. COUILLARD S, Pavord ID, Heaney LG, Petousi N, et al
    Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) framework.
    Respirology. 2022;27:573-577.
    >> Share

    July 2022
  57. PITZNER-FABRICIUS A, Clark VL, Backer V, Gibson PG, et al
    Factors associated with 6-min walk distance in severe asthma: A cross-sectional study.
    Respirology. 2022 Jul 10. doi: 10.1111/resp.14323.
    >> Share

  58. WANG KCW, Donovan GM, Saglani S, Mauad T, et al
    Growth of the airway smooth muscle layer from late gestation to childhood is mediated initially by hypertrophy and subsequently hyperplasia.
    Respirology. 2022;27:493-500.
    >> Share

    June 2022
  59. PEREZ-GARCIA J, Pino-Yanes M
    Novel insights into the biological pathways involved in severe asthma.
    Respirology. 2022 Jun 28. doi: 10.1111/resp.14319.
    >> Share

  60. SANCHEZ-OVANDO S, Pavlidis S, Kermani NZ, Baines KJ, et al
    Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts.
    Respirology. 2022 Jun 7. doi: 10.1111/resp.14302.
    >> Share

    February 2022
  61. COUILLARD S, Pavord ID
    Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma.
    Respirology. 2022 Feb 1. doi: 10.1111/resp.14213.
    >> Share

    January 2022
  62. ZHONG Y, Li L, Chen R, Zheng Q, et al
    Quantitative comparison of dose-effect and time-course of fluticasone furoate and fluticasone propionate in adult and adolescent patients with persistent asthma: A systematic review and meta-analysis.
    Respirology. 2022 Jan 18. doi: 10.1111/resp.14203.
    >> Share

  63. KOONER HK, McIntosh MJ, Desaigoudar V, Rayment JH, et al
    Pulmonary functional MRI: Detecting the structure-function pathologies that drive asthma symptoms and quality of life.
    Respirology. 2022 Jan 10. doi: 10.1111/resp.14197.
    >> Share

  64. LEE JW, Tay TR, Borg BM, Sheriff N, et al
    Laryngeal hypersensitivity and abnormal cough response during mannitol bronchoprovocation challenge.
    Respirology. 2022;27:48-55.
    >> Share

    December 2021
  65. DUAN P, Wang Y, Lin R, Zeng Y, et al
    Impact of early life exposures on COPD in adulthood: A systematic review and meta-analysis.
    Respirology. 2021;26:1131-1151.
    >> Share

    November 2021

  66. P1-10: Indicators of the pituitary-thyroid system in asthma patients with cold airway hyperresponsiveness without manifestation of thyroid lesion, living in endemic goiter area.
    Respirology. 2021;26 Suppl 3:73.
    >> Share


  67. P1-57: Kartagener's syndrome: A case report of a lady with poorly resolving asthma.
    Respirology. 2021;26 Suppl 3:95-96.
    >> Share

    October 2021
  68. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Respirology. 2021 Oct 19. doi: 10.1111/resp.14174.
    >> Share

  69. WATCHORN D, Menzies-Gow A
    Oral corticosteroid stewardship for asthma: Time to move from theory to routine clinical practice.
    Respirology. 2021 Oct 19. doi: 10.1111/resp.14171.
    >> Share

  70. MAJELLANO EC, Clark VL, Gibson PG, Foster JM, et al
    The needs and well-being of severe asthma and COPD carers: A cross-sectional study.
    Respirology. 2021 Oct 12. doi: 10.1111/resp.14167.
    >> Share

  71. OKYERE DO, Bui DS, Washko GR, Lodge CJ, et al
    Predictors of lung function trajectories in population-based studies: A systematic review.
    Respirology. 2021;26:938-959.
    >> Share

    September 2021
  72. BLAKEY J, Chung LP, McDonald VM, Ruane L, et al
    Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.
    Respirology. 2021 Sep 29. doi: 10.1111/resp.14147.
    >> Share

  73. BERGER P, Dupin I
    Unravelling the effects of omalizumab on fibrocytes.
    Respirology. 2021;26:825-827.
    >> Share

    April 2021
  74. LANGE P, Ahmed E, Lahmar ZM, Martinez FJ, et al
    Natural history and mechanisms of COPD.
    Respirology. 2021;26:298-321.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016